CapForce IBD 50 ETF
FFTY
71 hedge funds and large institutions have $53.1M invested in CapForce IBD 50 ETF in 2020 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 12 increasing their positions, 34 reducing their positions, and 9 closing their positions.
212% more call options, than puts
Call options by funds: $1.26M | Put options by funds: $403K
44% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 9
21% more capital invested
Capital invested by funds: $43.9M → $53.1M (+$9.19M)
6% more funds holding
Funds holding: 67 → 71 (+4)
0.55% more ownership
Funds ownership: 24.34% → 24.89% (+0.55%)
65% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 34
Top Buyers
Top Sellers
FFTY Hedge Fund Activity: Q2 2020 in Review
71 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in CapForce IBD 50 ETF (FFTY) for Q2 2020, worth a combined $53.1M — up 21% from $43.9M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new FFTY positions and 9 closed out — a net gain of 4 holders — while 12 added to existing stakes and 34 trimmed.
The largest buyer was Osaic Holdings, adding an estimated $4.33M. The largest seller was Raymond James Financial Services Advisors, cutting an estimated $2.22M.
- 71 institutional investors held CapForce IBD 50 ETF (FFTY) as of Q2 2020, up from 67 in Q1 2020.
- Funds reported $53.1M of CapForce IBD 50 ETF stock for Q2 2020, up 21% quarter-over-quarter.
- 13 funds opened new CapForce IBD 50 ETF positions in Q2 2020 and 9 closed out, a net change of +4 holders.
- The largest CapForce IBD 50 ETF buyer in Q2 2020 was Osaic Holdings, an estimated $4.33M added.
- The largest CapForce IBD 50 ETF seller in Q2 2020 was Raymond James Financial Services Advisors, an estimated $2.22M sold.
Based on aggregated 13F filings for Q2 2020.